
Sign up to save your podcasts
Or


This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill's conclusions.
By American College of Rheumatology5
1717 ratings
This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill's conclusions.

504 Listeners

297 Listeners

126 Listeners

2,456 Listeners

3,381 Listeners

1,144 Listeners

118 Listeners

8,018 Listeners

119 Listeners

365 Listeners

66 Listeners

5 Listeners

378 Listeners

181 Listeners

6 Listeners